GKOS GLAUKOS Corp

  1. Stocks
  2. Healthcare
  3. NYSE: GKOS

Price (delayed)

$52.33

Market cap

$2.49B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.19

Enterprise value

$2.76B

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, ...

Highlights
The gross margin has grown by 2.7% YoY
GLAUKOS's net income has shrunk by 101% QoQ but it has increased by 8% YoY
GLAUKOS's EPS has plunged by 95% from the previous quarter but it has increased by 9% YoY
The quick ratio has contracted by 24% from the previous quarter
GLAUKOS's equity has decreased by 6% QoQ and by 3.7% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.glaukos.com
Peers: BSX ICUI IART ATRC

Key stats

What are the main financial stats of GKOS
Market
Shares outstanding
47.6M
Market cap
$2.49B
Enterprise value
$2.76B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.4
Price to sales (P/S)
8.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.58
Earnings
Revenue
$288.32M
EBIT
-$42.07M
EBITDA
-$6.91M
Free cash flow
-$24.45M
Per share
EPS
-$1.19
Free cash flow per share
-$0.52
Book value per share
$11.88
Revenue per share
$6.09
TBVPS
$13.62
Balance sheet
Total assets
$1.03B
Total liabilities
$468.8M
Debt
$382.54M
Equity
$562.48M
Working capital
$401.59M
Liquidity
Debt to equity
0.68
Current ratio
6.78
Quick ratio
6.28
Net debt/EBITDA
-39.18
Margins
EBITDA margin
-2.4%
Gross margin
76.7%
Net margin
-19.4%
Operating margin
-11.7%
Efficiency
Return on assets
-5.3%
Return on equity
-9.5%
Return on invested capital
-4.9%
Return on capital employed
-4.4%
Return on sales
-14.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GKOS stock price

How has the GLAUKOS stock price performed over time
Intraday
-1.23%
1 week
-0.97%
1 month
7.17%
1 year
2.57%
YTD
17.75%
QTD
15.21%

Financial performance

How have GLAUKOS's revenue and profit performed over time
Revenue
$288.32M
Gross profit
$221.19M
Operating income
-$33.81M
Net income
-$55.8M
Gross margin
76.7%
Net margin
-19.4%
GKOS's operating income has shrunk by 200% QoQ but it is up by 32% YoY
The net margin has shrunk by 106% QoQ but it has increased by 8% YoY
GLAUKOS's net income has shrunk by 101% QoQ but it has increased by 8% YoY
The company's operating margin rose by 33% YoY

Growth

What is GLAUKOS's growth rate over time

Valuation

What is GLAUKOS stock price valuation
P/E
N/A
P/B
4.4
P/S
8.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.58
GLAUKOS's EPS has plunged by 95% from the previous quarter but it has increased by 9% YoY
The price to book (P/B) is 38% less than the 5-year quarterly average of 7.2 but 14% more than the last 4 quarters average of 3.9
GLAUKOS's equity has decreased by 6% QoQ and by 3.7% YoY
The P/S is 13% lower than the 5-year quarterly average of 10.0 but 10% higher than the last 4 quarters average of 7.9

Efficiency

How efficient is GLAUKOS business performance
The ROIC has dropped by 172% since the previous quarter but it is up by 36% year-on-year
The return on assets has dropped by 104% since the previous quarter but it is up by 10% year-on-year
The ROE has plunged by 102% from the previous quarter
GLAUKOS's ROS has increased by 10% YoY

Dividends

What is GKOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GKOS.

Financial health

How did GLAUKOS financials performed over time
The total assets is 120% greater than the total liabilities
The quick ratio has contracted by 24% from the previous quarter
GKOS's current ratio is down by 23% since the previous quarter
The debt is 32% lower than the equity
GLAUKOS's equity has decreased by 6% QoQ and by 3.7% YoY
The debt to equity has grown by 6% from the previous quarter and by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.